Role of distinct mitogen-activated protein kinase pathways and cooperation between Ets-2, ATF-2, and Jun family members in human urokinase- type plasminogen activator gene induction by interleukin-1 and tetradecanoyl phorbol acetate

Molecular and Cellular Biology

Volumn 19, Issue 9, 1999, Pages 6240-6252

  Cirillo, Grazia ^a   Casalino, Laura ^a   Vallone, Daniela ^a,b   Caracciolo, Anna ^a,c   De Cesare, Dario ^a,b   Verde, Pasquale ^a  

^a INSTITUTE OF GENETICS AND BIOPHYSICS ADRIANO BUZZATI TRAVERSO   (Italy)

^b INSTITUT DE GÉNÉTIQUE ET DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

^c STAZIONE ZOOLOGICA ANTON DOHRN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1; MITOGEN ACTIVATED PROTEIN KINASE; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN KINASE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR AP 1; UROKINASE;

ARTICLE; CELL STRAIN HEPG2; CONTROLLED STUDY; ENHANCER REGION; ENZYME ACTIVATION; GENE INDUCTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; TRANSCRIPTION REGULATION;

EID: 0032793301     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.19.9.6240     Document Type: Article

References (58)

1. Andreasen, P. A., L. Kjoller, L. Christensen, and M. J. Duffy. 1997. The urokinase-type plasminogen activator system in cancer metastasis: a review. Int. J. Cancer 72:1-22.
2. Angel, P., and M. Karin. 1991. The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation. Biochim. Biophys. Acta 1072:129-157.
3. Baumann, H., K. K. Morella, and G. H. Wong. 1993. TNF-alpha, IL-1 beta, and hepatocyte growth factor cooperate in stimulating specific acute phase plasma protein genes in rat hepatoma cells. J. Immunol. 151:4248-4257.
4. Berthelsen, J., J. Vandekerkhove, and F. Blasi. 1996. Purification and characterization of UEF3, a novel factor involved in the regulation of the urokinase and other AP-1 controlled promoters. J. Biol. Chem. 271:3822-3830.
5. Besser, D., M. Presta, and Y. Nagamine. 1995. Elucidation of a signaling pathway induced by FGF-2 leading to uPA gene expression in NIH 3T3 fibroblasts. Cell Growth Differ. 6:1009-1107.
6. Besser, D., M. Urich, M. Sakaue, A. Messerschmitt, K. Ballmer-Hofer, and Y. Nagamine. 1995. Urokinase-type plasminogen activator gene regulation by polyomavirus middle-T antigen. Oncogene 11:2383-2391.
7. Besser, D., P. Verde, Y. Nagamine, and F. Blasi. 1996. Signal transduction and the uPA/uPAR system. Fibrinolysis 10:215-237.
8. Bird, T. A., J. M. Kyriakis, L. Tyshler, M. Gayle, A. Milne, and G. D. Virca. 1994. Interleukin-1 activates p54 mitogen-activated protein (MAP) kinase/ stress-activated protein kinase by a pathway that is independent of p21ras, Raf-1, and MAP kinase kinase. J. Biol. Chem. 269:31836-31844.
9. Blasi, F. 1993. Urokinase and urokinase receptor: a paracrine/autocrine system regulating cell migration and invasiveness. Bioessays 15:105-111.
10. Blasi, F., and P. Verde. 1990. Urokinase-dependent cell surface proteolysis and cancer. Semin. Cancer Biol. 1:117-126.
11. Bruder, J. T., G. Heidecker, and U. R. Rapp. 1992. Serum-, TPA-, and Ras-induced expression from Ap-1/Ets-driven promoters requires Raf-1 kinase. Genes Dev. 6:545-556.
12. Busso, N., E. Nicodeme, C. Chesne, A. Guillouzo, D. Belin, and F. Hyafil. 1994. Urokinase and type I plasminogen activator inhibitor production by normal human hepatocytes: modulation by inflammatory agents. Hepatology 20:186-190.
13. Campbell, I. K., D. S. Piccoli, D. M. Butler, D. K. Singleton, and J. A. Hamilton. 1988. Recombinant human interleukin-1 stimulates human articular cartilage to undergo resorption and human chondrocytes to produce both tissue- and urokinase-type plasminogen activator. Biochim. Biophys. Acta 967:183-194.
14. Cano, E., C. A. Hazzalin, and L. C. Mahadevan. 1994. Anisomycin-activated protein kinases p45 and p55 but not mitogen-activated protein kinases ERK-1 and -2 are implicated in the induction of c-fos and c-jun. Mol. Cell. Biol. 14:7352-7362.
15. Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156-159.
16. De Cesare, D., M. Palazzolo, J. Berthelsen, and F. Blasi. 1997. Characterization of UEF-4, a DNA-binding protein required for transcriptional synergism between two AP-1 sites in the human urokinase enhancer. J. Biol. Chem. 272:23921-23929.
17. De Cesare, D., M. Palazzolo, and F. Blasi. 1996. Functional characterization of COM, a DNA region required for cooperation between AP-1 sites in urokinase gene transcription. Oncogene 13:2551-2562.
18. De Cesare, D., D. Vallone, A. Caracciolo, P. Sassone-Corsi, C. Nerlov, and P. Verde. 1995. Heterodimerization of c-Jun with ATF-2 and c-Fos is required for positive and negative regulation of the human urokinase enhancer. Oncogene 11:365-376.
19. Derijard, B., M. Hibi, I. H. Wu, T. Barrett, B. Su, T. Deng, M. Karin, and R. J. Davis. 1994. JNK1: a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain. Cell 76:1025-1037.
20. D'Orazio, D., D. Besser, R. Marksitzer, C. Kunz, D. A. Hume, B. Kiefer, and Y. Nagamine. 1997. Cooperation of two PEA3/AP1 sites in uPA gene induction by TPA and FGF-2. Gene 201:179-187.
21. El-Shemerly, M. Y., D. Besser, M. Nagasawa, and Y. Nagamine. 1997. 12-O-Tetradecanoylphorbol-13-acetate activates the Ras/extracellular signal-regulated kinase (ERK) signaling pathway upstream of SOS involving serine phosphorylation of Shc in NIH3T3 cells. J. Biol. Chem. 272:30599-30602.
22. Fowles, L. F., M. L. Martin, L. Nelsen, K. J. Stacey, D. Redd, Y. M. Clark, Y. Nagamine, M. McMahon, D. A. Hume, and M. C. Ostrowski. 1998. Persistent activation of mitogen-activated protein kinases p42 and p44 and ets-2 phosphorylation in response to colony-stimulating factor 1/c-fms signaling. Mol. Cell. Biol. 18:5148-5156.
23. Galang, C. K., C. J. Der, and C. A. Hauser. 1994. Oncogenic Ras can induce transcriptional activation through a variety of promoter elements, including tandem c-Ets-2 binding sites. Oncogene 9:2913-2921.
24. Gupta, S., T. Barrett, A. J. Whitmarsh, J. Cavanagh, H. K. Sluss, B. Derijard, and R. J. Davis. 1996. Selective interaction of JNK protein kinase isoforms with transcription factors. EMBO J. 15:2760-2770.
25. Gupta, S., D. Campbell, B. Derijard, and R. J. Davis. 1995. Transcription factor ATF2 regulation by the JNK signal transduction pathway. Science 267:389-393.
26. Gutman, A., and B. Wasylyk. 1990. The collagenase gene promoter contains a TPA and oncogene-responsive unit encompassing the Pea3 and AP-1 binding sites. EMBO J. 9:2241-2246.
27. Gutman, A., and B. Wasylyk. 1991. Nuclear targets for transcription regulation by oncogenes. Trends Genet. 7:49-54.
28. Irigoyen, J. P., D. Besser, and Y. Nagamine. 1997. Cytoskeleton reorganization induces the urokinase-type plasminogen activator gene via the Ras/ extracellular signal-regulated kinase (ERK) signaling pathway. J. Biol. Chem. 272:1904-1909.
29. Kallunki, T., T. Deng, M. Hibi, and M. Karin. 1996. c-Jun can recruit JNK to phosphorylate dimerization partners via specific docking interactions. Cell 87:929-939.
30. Karin, M. 1995. The regulation of AP-1 activity by mitogen-activated protein kinases. J. Biol. Chem. 270:16483-16486.
31. Kawasaki, H., J. Song, R Eckner, H. Ugai, R. Chiu, K. Taira, Y. Shi, N. Jones, and K. K. Yokoyama. 1998. p300 and ATF-2 are components of the DRF complex, which regulates retinoic acid- and E1A-mediated transcription of the c-jun gene in F9 cells. Genes Dev. 12:233-245.
32. Kim, T. H., W. M. Mars, D. B. Stolz, B. E. Petersen, and G. K. Michalopoulos. 1997. Extracellular matrix remodeling at the early stages of liver regeneration in the rat. Hepatology 26:896-904.
33. Kortenjann, M., O. Thomae, and P. E. Shaw. 1994. Inhibition of v-raf-dependent c-fos expression and transformation by a kinase-defective mutant of the mitogen-activated protein kinase Erk2. Mol. Cell. Biol. 14:4815-4824.
34. Langer, S. J., D. M. Bortner, M. F. Roussel, C. J. Sherr, and M. C. Ostrowski. 1992. Mitogenic signaling by colony-stimulating factor 1 and ras is suppressed by the ets-2 DNA-binding domain and restored by myc overexpression. Mol. Cell. Biol. 12:5355-5362.
35. Lengyel, E., B. Singh, R. Gum, C. Nerlov, A. Sabichi, M. Birrer, and D. Boyd. 1995. Regulation of urokinase-type plasminogen activator expression by the v-mos oncogene. Oncogene 11:2639-2648.
36. Lengyel, E., E. Stepp, R. Gum, and D. Boyd. 1995. Involvement of a mitogen-activated protein kinase signaling pathway in the regulation of urokinase promoter activity by c-Ha-ras. J. Biol. Chem. 270:23007-23012.
37. Livingstone, C., G. Patel, and N. Jones. 1995. ATF-2 contains a phosphorylation-dependent transcriptional activation domain. EMBO J. 14:1785-1797.
38. Logan, S. K., M. J. Garabedian, C. E. Campbell, and Z. Werb. 1996. Synergistic transcriptional activation of the tissue inhibitor of metalloproteinases-1 promoter via functional interaction of AP-1 and Ets-1 transcription factors. J. Biol. Chem. 271:774-782.
39. Mahadevan, L. C., and D. R. Edwards. 1991. Signalling and superinduction. Nature 349:747-748. (Letter.)
40. Majka, S. M., and P. G. McGuire. 1997. Regulation of urokinase expression in the developing avian heart: a role for the Ets-2 transcription factor. Mech. Dev. 68:127-137.
41. Marshall, B. C., Q. P. Xu, N. V. Rao, B. R. Brown, and J. R. Hoidal. 1992. Pulmonary epithelial cell urokinase-type plasminogen activator. Induction by interleukin-1 beta and tumor necrosis factor-alpha. J. Biol. Chem. 267: 11462-11469.
42. Miralles, F., M. Parra, C. Caelles, Y. Nagamine, J. Felez, and P. Munoz-Canoves. 1998. UV irradiation induces the murine urokinase-type plasminogen activator gene via the c-Jun N-terminal kinase signaling pathway: requirement of an API enhancer element. Mol. Cell. Biol. 18:4537-4547.
43. Naldini, L., L. Tamagnone, E. Vigna, M. Sachs, G. Hartmann, W. Birchmeier, Y. Daikuhara, H. Tsubouchi, F. Blasi, and P. M. Comoglio. 1992. Extracellular proteolytic cleavage by urokinase is required for activation of hepatocyte growth factor/scatter factor. EMBO J. 11:4825-4833.
44. Nerlov, C., D. De Cesare, F. Pergola, A. Caracciolo, F. Blasi, M. Johnsen, and P. Verde. 1992. A regulatory element that mediates co-operation between a PEA3-AP-1 element and an AP-1 site is required for phorbol ester induction of urokinase enhancer activity in HepG2 hepatoma cells. EMBO J. 11:4573-4582.
45. Nerlov, C., P. Rørth, F. Blasi, and M. Johnsen. 1991. Essential AP-1 and PEA3 binding elements in the human urokinase enhancer display cell type-specific activity. Oncogene 6:1583-1592.
46. O'Hagan, R. C., and J. A. Hassell. 1998. The PEA3 Ets transcription factor is a downstream target of the HER2/Neu receptor tyrosine kinase. Oncogene 16:301-310.
47. O'Hagan, R. C., R. G. Tozer, M. Symons, F. McCormick, and J. A. Hassell. 1996. The activity of the Ets transcription factor PEA3 is regulated by two distinct MAPK cascades. Oncogene 13:1323-1333.
48. Pages, G., P. Lenormand, G. L'Allemain, J. C. Chambard, S. Meloche, and J. Pouyssegur. 1993. Mitogen-activated protein kinases p42mapk and p44mapk are required for fibroblast proliferation. Proc. Natl. Acad. Sci. USA 90:8319-8323.
49. Reimold, A. M., M. J. Grusby, B. Kosaras, J. W. Fries, R. Mori, S. Maniwa, I. M. Clauss, T. Collins, R. L. Sidman, M. J. Glimcher, and L. H. Glimcher. 1996. Chondrodysplasia and neurological abnormalities in ATF-2-deficient mice. Nature 379:262-265.
50. Rørth, P., C. Nerlov, F. Blast, and M. Johnsen. 1990. Transcription factor PEA3 participates in the induction of urokinase plasminogen activator transcription in murine keratinocytes stimulated with epidermal growth factor or phorbol ester. Nucleic Acids Res. 18:5009-5017.
51. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
52. Stacey, K. J., L. F. Fowles, M. S. Colman, M. C. Ostrowski, and D. A. Hume. 1995. Regulation of urokinase-type plasminogen activator gene transcription by macrophage colony-stimulating factor. Mol. Cell. Biol. 15:3430-3441.
53. Vallone, D., S. Battista, G. M. Plerantoni, M. Fedele, L. Casalino, M. Santoro, G. Viglietto, A. Fusco, and P. Verde. 1997. Neoplastic transformation of rat thyroid cells requires the junB and fra-1 gene induction which is dependent on the HMGI-C gene product. EMBO J. 16:5310-5321.
54. Verde, P., S. Boast, A. Franze, F. Robbiati, and F. Blasi. 1988. An upstream enhancer and a negative element in the 5′ flanking region of the human urokinase plasminogen activator gene. Nucleic Acids Res. 16: 10699-10716.
55. Wasylyk, C., A. P. Bradford, A. Gutierrez-Hartmann, and B. Wasylyk. 1997. Conserved mechanisms of Ras regulation of evolutionary related transcription factors, Ets1 and Pointed P2. Oncogene 14:899-913.
56. Whitmarsh, A. J., P. Shore, A. D. Sharrocks, and R. J. Davis. 1995. Integration of MAP kinase signal transduction pathways at the serum response element. Science 269:403-407.
57. Yamamoto, H., M. L. Flannery, S. Kupriyanov, J. Pearce, S. R. McKercher, G. W. Henkel, R. A. Maki, Z. Werb, and R. G. Oshima. 1998. Defective trophoblast function in mice with a targeted mutation of Ets2. Genes Dev. 12:1315-1326.
58. Yang, B.-S., C. A. Hauser, G. Henkel, M. S. Colman, C. Van Beveren, K. J. Stacey, D. A. Hume, R. A. Maki, and M. C. Ostrowski. 1996. Ras-mediated phosphorylation of a conserved threonine residue enhances the transactivation activities of c-Ets1 and c-Ets2. Mol. Cell. Biol. 16:538-547.